Dashboard
Manage Tickers

MASIMASIMO CORP

Nasdaq masimo.com


$ 132.52 $ 3.70 (2.87 %)    

Tuesday, 25-Jun-2024 15:59:56 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 479.35 $ 5.42 (1.14 %)
DIA $ 391.06 $ -2.96 (-0.75 %)
SPY $ 544.78 $ 2.09 (0.39 %)
TLT $ 94.49 $ 0.16 (0.17 %)
GLD $ 214.55 $ -1.07 (-0.5 %)
$ 132.43
$ 129.04
$ 0.00 x 0
$ 0.00 x 0
$ 128.58 - $ 133.04
$ 75.22 - $ 167.04
475,072
na
7.18B
$ 0.90
$ 90.74
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-07-2024 03-30-2024 10-Q
2 02-28-2024 12-30-2023 10-K
3 11-08-2023 09-30-2023 10-Q
4 08-08-2023 07-01-2023 10-Q
5 05-10-2023 04-01-2023 10-Q
6 03-01-2023 12-31-2022 10-K
7 11-09-2022 10-01-2022 10-Q
8 08-10-2022 07-02-2022 10-Q
9 05-03-2022 04-02-2022 10-Q
10 02-15-2022 01-01-2022 10-K
11 10-26-2021 10-02-2021 10-Q
12 07-27-2021 07-03-2021 10-Q
13 04-27-2021 04-03-2021 10-Q
14 02-23-2021 01-02-2021 10-K
15 10-27-2020 09-26-2020 10-Q
16 07-28-2020 06-27-2020 10-Q
17 04-28-2020 03-28-2020 10-Q
18 02-19-2020 12-28-2019 10-K
19 10-30-2019 09-28-2019 10-Q
20 07-31-2019 06-29-2019 10-Q
21 05-06-2019 03-30-2019 10-Q
22 02-26-2019 12-29-2018 10-K
23 10-31-2018 09-29-2018 10-Q
24 08-01-2018 06-30-2018 10-Q
25 05-07-2018 03-31-2018 10-Q
26 02-28-2018 12-30-2017 10-K
27 10-31-2017 09-30-2017 10-Q
28 08-02-2017 07-01-2017 10-Q
29 05-04-2017 04-01-2017 10-Q
30 02-15-2017 12-31-2016 10-K
31 11-02-2016 10-01-2016 10-Q
32 08-03-2016 07-02-2016 10-Q
33 05-04-2016 04-02-2016 10-Q
34 02-24-2016 01-02-2016 10-K
35 11-06-2015 10-03-2015 10-Q
36 08-04-2015 07-04-2015 10-Q
37 05-06-2015 04-04-2015 10-Q
38 02-17-2015 01-03-2015 10-K
39 10-29-2014 09-27-2014 10-Q
40 08-07-2014 06-28-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

masimo-secures-dismissal-of-infringement-lawsuit-filed-by-wrist-sp-biotech
Masimo Secures Dismissal Of Infringement L...
06/24/2024 13:05:58

Knobbe Martens secured another victory for Masimo Corporation (NASDAQ:MASI) with the successful dismissal with prejudice of a p...

masimo-issued-a-statement-to-set-the-record-straight-regarding-politans-background-of-the-solicitation-section-of-its-proxy-statement-issued-in-connection-with-masimos-upcoming-annual-meeting-of-stockholders
Masimo Issued A Statement To Set The Recor...
06/20/2024 10:09:26

why-smartsheet-shares-are-trading-higher-by-13-here-are-20-stocks-moving-premarket
Why Smartsheet Shares Are Trading Higher B...
06/06/2024 12:16:55

12-health-care-stocks-moving-in-thursdays-pre-market-session
12 Health Care Stocks Moving In Thursday's...
06/06/2024 12:07:48

five-below-posts-weak-q1-results-joins-sprinklr-dorian-lpg-and-other-big-stocks-moving-lower-in-thursdays-pre-market-session
Five Below Posts Weak Q1 Results, Joins Sp...
06/06/2024 09:40:18

politan-capital-management-files-preliminary-proxy-statement-in-connection-with-its-nomination-of-two-independent-candidates-for-election-to-the-masimo-board-of-directors-says-masimos-nomination-of-christopher-chavez-reflects-a-continued-unwillingness-to-add-truly-independent-directors-to-the-masimo-board
Politan Capital Management Files Prelimina...
06/03/2024 13:01:13

Highlights That Politan's Independent and Ideally Qualified Nominees Dr. Darlene Solomon and William Jellison Are Urgently ...

assessing-masimo-insights-from-6-financial-analysts
Assessing Masimo: Insights From 6 Financia...
06/03/2024 13:00:37

piper-sandler-upgrades-masimo-to-overweight-raises-price-target-to-160
Piper Sandler Upgrades Masimo to Overweigh...
06/03/2024 12:28:47

Piper Sandler analyst Jason Bednar upgrades Masimo (NASDAQ:MASI) from Neutral to Overweight and raises the price target from...

barcelona-hospital-launches-masimo-powered-telehealth-initiative-with-advanced-wearable-tech
Barcelona Hospital Launches Masimo-Powered...
06/03/2024 07:13:22

Masimo (NASDAQ:MASI) today announced that Germans Trias i Pujol, a pioneering hospital serving more than 800,000 people in nort...

medable-has-partnered-with-masimo-to-bring-medical-grade-wearable-devices-to-clinical-research
Medable Has Partnered With Masimo To Bring...
05/29/2024 11:27:20

masimo-denon-unveil-white-perl-and-perl-pro-earbuds-redefining-style-and-customization-in-personalized-audio
Masimo, Denon Unveil White PerL And PerL P...
05/16/2024 11:51:22

politan-capital-management-proposes-to-add-darlene-solomon-and-bill-jellison-to-masimos-board-immediately
Politan Capital Management Proposes To Add...
05/09/2024 19:56:08

- Reuters

politan-capital-management-responds-to-masimos-proposal-that-it-withdraw-nominations-in-return-for-1-nominee-on-masimos-board-says-falls-well-short-of-resolving-the-fundamental-governance-problems-at-masimo-needs-a-majority-of-truly-independent-directors-will-not-oppose-re-election-of-joe-kiani-to-the-board
Politan Capital Management Responds To Mas...
05/09/2024 19:55:42

- Reuters

why-upstart-shares-are-trading-lower-by-around-10-here-are-other-stocks-moving-in-wednesdays-mid-day-session
Why Upstart Shares Are Trading Lower By Ar...
05/08/2024 17:38:56

piper-sandler-maintains-neutral-on-masimo-raises-price-target-to-126
Piper Sandler Maintains Neutral on Masimo,...
05/08/2024 12:15:31

Piper Sandler analyst Jason Bednar maintains Masimo (NASDAQ:MASI) with a Neutral and raises the price target from $117 to $126.

needham-reiterates-hold-on-masimo
Needham Reiterates Hold on Masimo
05/08/2024 10:40:28

Needham analyst Mike Matson reiterates Masimo (NASDAQ:MASI) with a Hold.

masimo-revises-fy24-revenue-forecast-from-2045b-2165b-to-2055b-2165b-est-2102b-adj-eps-from-344---360-to-354---370-est-352
Masimo Revises FY24 Revenue Forecast From ...
05/07/2024 20:57:17

masimo-expects-q2-consolidated-revenue-of-480m-510m-est-503791m-adj-eps-of-073-079-est-077
Masimo Expects Q2 Consolidated Revenue Of ...
05/07/2024 20:45:55

masimo-q1-2024-adj-eps-077-beats-069-estimate-sales-492800m-beat-487554m-estimate
Masimo Q1 2024 Adj EPS $0.77 Beats $0.69 E...
05/07/2024 20:08:00

Masimo (NASDAQ:MASI) reported quarterly earnings of $0.77 per share which beat the analyst consensus estimate of $0.69 by 11.59...

masimo-receives-fda-clearance-for-stork-over-the-counter-otc-baby-monitoring-system
Masimo Receives FDA Clearance for Stork Ov...
05/06/2024 12:03:56

Masimo (NASDAQ:MASI), a global leader in innovative monitoring technologies currently celebrating its 35th anniversary, announc...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION